Miller Fisher variant of Guillain-Barré syndrome requiring a cardiac pacemaker in a patient on tacrolimus after liver transplantation

Annals of Pharmacotherapy

Volumn 39, Issue 6, 2005, Pages 1124-1127

  Kaushik, Prashant ^a   Cohen, Ari J ^b   Zuckerman, Steven J ^a   Vatsavai, Sundararama R ^a   Pepper, Jeremy S ^c   Banda, Venkatramana R ^a   Eason, James D ^b   Loss Jr , George E ^b   Kaushik, Richa ^a  

^a Baton Rouge General   (United States)

^b OCHSNER CLINIC FOUNDATION   (United States)

^c LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

Guillain Barr syndrome; Liver transplantation; Miller Fisher syndrome; Tacrolimus

Indexed keywords

IMMUNOGLOBULIN; TACROLIMUS;

ADULT; ANAMNESIS; AREFLEXIA; ARTICLE; ATAXIA; CASE REPORT; CLINICAL EXAMINATION; DIAGNOSTIC IMAGING; DYSAUTONOMIA; GUILLAIN BARRE SYNDROME; HEART PACING; HUMAN; IMMUNOTHERAPY; LABORATORY TEST; LIVER TRANSPLANTATION; MALE; NEUROLOGIC EXAMINATION; OPHTHALMOPLEGIA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANTILYMPHOCYTE SERUM; CARDIAC PACING, ARTIFICIAL; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MILLER FISHER SYNDROME; TACROLIMUS; WITHHOLDING TREATMENT;

EID: 18844440983     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1E676     Document Type: Article

References (15)

1. Eidelman BH, Abu-Elmgad K, Wilson J, Fung JJ, Alessiani M, Jain A, et al. Neurologic complications of FK506. Transplant Proc 1991;23:3175-8.
2. Wijdicks EFM, Wiessner RH, Dahlke LJ, Krom RAF. FK506 induced neurotoxicity in liver transplantation. Ann Neurol 1994;35:498-501.
3. Fisher M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med 1956;255:57-65.
4. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990;27(suppl):S21-4.
5. Wilson JR, Conwit RA, Eidelman BH, Starzl T, Abu-Elmgad K. Sensorimotor neuropathy resembling CIDP in patients receiving FK506. Muscle Nerve 1994;17:528-32.
6. Echaniz-Laguna A, Battaglia F, Ellero B, Mohr M, Jaeck D. Chronic inflammatory demyelinating polyradiculoneuropathy in patients with liver transplantation. Muscle Nerve 2004;30:501-4.
7. Bechstein WO. Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transpl Int 2000;13:313-26.
8. Shutter LA, Green JP, Newman NJ, Hooks MA, Gordon RD. Cortical blindness and white matter lesions in a patient receiving FK506 after liver transplantation. Neurology 1993;43:2417-8.
9. Brazis PW, Spivey JR, Bolling JP, Steers JL. A case of bilateral optic neuropathy in a patient on tacrolimus (FK506) therapy after liver transplantation. Am J Ophthalmol 2000;129:536-8.
10. Roberts T, Shah A, Graham JG, McQueen INF. The Miller Fisher syndrome following Campylobacter enteritis: a report of two cases. J Neurol Neurosurg Psychiatry 1987;50:1557-8.
11. Colle I, Van Vlierberghe H, Troisi R, De Ridder K, Benoit D, de Hemptine B, et al. Campylobacter-associated Guillain-Barré syndrome after orthotopic liver transplantation for hepatitis C cirrhosis: a case report. Hepatol Res 2002;24:205-11.
12. Stein DP, Lederman RJ, Vogt DP, Carey WD, Broughan TA. Neurological complications following liver transplantation. Ann Neurol 1992;31: 644-9.
13. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
14. Eason JD, Nair S, Cohen AJ, Blazek JL, Loss GE Jr. Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy. Transplantation 2003;75:1396-9.
15. Maramattom BV, Wijdicks EF. Sirolimus may not cause neurotoxicity in kidney and liver transplant recipients. Neurology 2004;63:1958-9.